iNotify ApS
Core data
Name | iNotify ApS |
Address | Ole Maaløes Vej 3, 2200, København N |
Founded | Sep 17, 2021 |
Employees (CVR) | 4 |
Locations (P-units) | 1View locations |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | iNotify ApS |
Address | Ole Maaløes Vej 3, 2200, København N |
Founded | Sep 17, 2021 |
Employees (CVR) | 4 |
Locations (P-units) | 1View locations |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of iNotify ApS
Description
Notify Therapeutics is engaged in the discovery and development of drug products for treating infertility in women, based on the foundational science and intellectual property around new NTY series, which can utilize a new mechanism to promote egg formation and increase life birth.
Financials
| Reporting period | 2025EUR | |||
|---|---|---|---|---|
| Gross profit | -40,215 | |||
| Operating profit | -514,098 | |||
| Profit before tax | -508,516 | |||
| Net income | -386,474 | |||
| Total assets | 735,834 | |||
| Equity | 691,981 | |||
| Avg. employees | 3 | |||
2022–2025 Unlock financial history | ||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Contact
No contact details have been registered for this company.
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
Founders
| Founder | Registered as founder | Current roles | Ownership |
|---|---|---|---|
| Anders Heuck | Registered as founderSep 17, 2021 | Current roles — | Ownership — |
| Emil Hagen Ernst | Registered as founderSep 17, 2021 | Current roles — | Ownership — |
| Karin Lykke-Hartmann | Registered as founderSep 17, 2021 | Current roles Management | Ownership 33.33–49.99 %Indirect via Karin Lykke-Hartmann Holding ApS |
| Mahboobeh Amoushahi | Registered as founderSep 17, 2021 | Current roles — | Ownership — |
People
| Person | Roles | Titles |
|---|---|---|
| Henrik Stage | Roles Board | TitlesBESTYRELSESMEDLEM |
| Jacob Falck Hansen | Roles Board | TitlesBESTYRELSESMEDLEM |
| Karin Lykke-Hartmann | Roles Management | TitlesADM. DIR. |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| EY Godkendt Revisionspartnerselskab | AuditorPeter U. Faurschou | RoleState Authorised Public Accountant | FromJun 22, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership33.33–49.99 % | Voting rights33.33 % | FromSep 26, 2023 | |
| Ownership15–19.99 % | Voting rights15 % | FromMar 20, 2024 | |
| Ownership10–14.99 % | Voting rights10 % | FromSep 26, 2023 | |
Unknown Other Participant | Ownership10–14.99 % | Voting rights10 % | FromSep 26, 2023 |
| Ownership5–9.99 % | Voting rights5 % | FromOct 28, 2022 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| Karin Lykke-Hartmann | Ownership through | 33.33–49.99 % |
| BioInnovation Institute Fonden | Ownership through | 15–19.99 % |
| LUNDBECKFONDEN | Ownership through | 10–14.99 % |
| 🇰🇾NanoDimension IV, L.P. | Ownership through Direct | 10–14.99 % |
| Henrik Stage | Ownership through | 5–9.99 % |